PEYONA

This brand name is authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug PEYONA contains one active pharmaceutical ingredient (API):

1	Caffeine UNII U26EO4675Q - CAFFEINE CITRATE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PEYONA Solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BC01	Caffeine	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BC Xanthine derivatives
Discover more medicines within N06BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	508513060011102
CA	Health Products and Food Branch	02496771
EE	Ravimiamet	1426823, 1484276
ES	Centro de información online de medicamentos de la AEMPS	09528002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	414022
GB	Medicines & Healthcare Products Regulatory Agency	205319
HK	Department of Health Drug Office	64696
IT	Agenzia del Farmaco	040889014, 040889026
LT	Valstybinė vaistų kontrolės tarnyba	1050689, 1056077
NL	Z-Index G-Standaard, PRK	101079
PL	Rejestru Produktów Leczniczych	100245767
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56359001, W56359002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699822760302